GCG and metabolic dysfunction-associated steatotic liver disease: Consistently, our meta-analysis suggests a possible beneficial class effect of GLP-1 RAs on serum liver enzyme levels and imaging-detected liver fat content of patients with NAFLD and type 2 diabetes.